Varex Imaging Corporation (VREX) Financials

VREX Assets vs Liabilities

DateAssetsLiabilities
June 30, 2026 1.1 billion 589.5 million
March 31, 2026 1.1 billion 601.3 million
Dec. 31, 2025 1.1 billion 607.2 million
Sept. 30, 2025 1.1 billion 620.8 million

VREX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 12.0 million 3.8 million
March 31, 2026 -7.7 million 4.0 million
Dec. 31, 2025 -26.8 million 3.8 million
Sept. 30, 2025 2.3 million 3.4 million

VREX Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 15.9 million
March 31, 2026 -8.1 million
Dec. 31, 2025 2.3 million
Sept. 30, 2025 12.2 million

VREX Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 99.2 million 328.9 million 26.5 million
March 31, 2026 88.3 million 329.0 million 28.3 million
Dec. 31, 2025 125.6 million 366.2 million 27.9 million
Sept. 30, 2025 155.1 million 366.0 million 29.6 million

VREX Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 42.6 million
March 31, 2026 41.9 million
Dec. 31, 2025 42.3 million
Sept. 30, 2025 41.8 million

VREX Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 9.0 million 23.3 million 30.6 million -
March 31, 2026 6.2 million 22.2 million 36.0 million -
Dec. 31, 2025 10.7 million 21.7 million 32.7 million -
Sept. 30, 2025 5.6 million 24.2 million 34.0 million -

VREX Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 210.5 million 133.8 million
March 31, 2026 216.0 million 143.4 million
Dec. 31, 2025 209.6 million 139.8 million
Sept. 30, 2025 228.9 million 151.1 million

VREX Revenue by Segment

Graph available only for paid members. Upgrade to see it.

VREX

Price: $18.50

52 week price:
9.09
18.63

Payout Ratio Range:
6.17%
2142.45%

Earnings Per Share: 0.53 USD

P/E Ratio: 34.89

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 239000

Ebitda: 21.7 million

Market Capitalization: 779.7 million

Links: